Synta gets good news with lead cancer drug in blood cancer trial

An experimental drug by Synta Pharmaceuticals that has been in recent trials against lung, breast and ovarian cancer will move into a late-stage head-to-head test against other promising drugs to treat elderly patients with newly-diagnosed blood cancer...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.